The GSK Code sets out the commitments GSK and our people make to get ahead together – so we can deliver on our ambition in the right way, bring our culture to life and make GSK an exciting and inspiring place to work.
The Anti-Bribery and Corruption (ABAC) Programme is part of GSK’s response to the threat and risk of bribery and corruption. The programme includes an ABAC Policy and Standard, which have been designed to help staff and external parties understand bribery and corruption risk, and their responsibilities to actively combat it.
The Financial Conflicts of Interest policy is a National Institutes of Health specific supplement to GSK’s Conflict of Interest and Anti-Bribery and Corruption policies to incorporate specific US federal regulatory requirements intended to promote and encourage transparency and avoid inappropriate use of US Public Health Service funding. This policy helps ensure that government funded research is conducted without bias and with the highest scientific and ethical standards by principle investigators.
Our annual Modern Slavery Act statement, as required by the Modern Slavery Act 2015 (“the Act”), provides details on the controls we have adopted to ensure that modern slavery and human trafficking do not take place in our supply chain or in any part of our business. The statement covers our financial year which runs from 1 January to 31 December.
Our Third Party Oversight Programme helps control risks from third party business engagements with suppliers, distributors and other business partners. We want to work with business partners who share our commitment of high ethical standards and operating in a responsible way.
As detailed in our Code of Conduct, we do not tolerate harassment, unwelcome, unreasonable or offensive behaviour or discrimination of any kind. Our Equal and Inclusive Treatment policy is designed to help our employees and complementary workers understand their role in ensuring GSK is a company where all employees are treated equally.
Our human resources and research and development activities involve the processing of “personal information”, including the transfer of that personal information internationally. We have adopted Binding Corporate Rules (BCRs) to enable us to make international transfers of personal information within our group of companies in compliance with data protection laws of the European Union, in particular the General Data Protection Regulation (Regulation 2016/679) (GDPR).
GSK is committed to protecting people and the environment, moving towards our sustainability ambitions and promoting wellbeing and the safety of our people. Our Environment, Health and Safety policy sets out our approach to managing EHS risks and creating opportunities across our organisation to fulfil our EHS protection commitments, both internally and externally.
Occupational Health and Safety is part of EHS at GSK and information on our management systems can be found in our Occupational Health and Safety report.